- Home
- AUDC vs MGTX Comparison
AUDC vs MGTX Comparison
Compare AUDC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUDC | MGTX |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.0M | 744.9M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUDC | MGTX |
|---|---|---|
| Price | $9.13 | $8.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $11.67 | ★ $23.83 |
| AVG Volume (30 Days) | 111.8K | ★ 643.1K |
| Earning Date | 02-03-2026 | 11-13-2025 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | ★ 15.76 | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $244,553,000.00 | $27,417,000.00 |
| Revenue This Year | $2.52 | N/A |
| Revenue Next Year | $3.15 | $619.95 |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | 0.15 | ★ 96.83 |
| 52 Week Low | $8.01 | $4.55 |
| 52 Week High | $12.72 | $9.73 |
Technical Indicators
Market Signals| Indicator | AUDC | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 44.34 |
| Support Level | $8.79 | $8.25 |
| Resistance Level | $9.20 | $9.50 |
| Average True Range (ATR) | 0.24 | 0.56 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 74.56 | 21.32 |
Price Performance
Historical ComparisonAbout AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.